Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2014, Vol. 34 Issue (3): 9-17    DOI: 10.13523/j.cb.20140302
    
The Inhibition of Ad. RGD-ING4-PTEN on MEG01 Human Leukemia Cell
HUANG Chen, WANG Jia-rong, YANG Ji-cheng, SHENG Wei-hua, MIAO Jing-cheng
Medical College of Soochow University, Cell and Molecular Biology Institute, Suzhou 215123, China
Download: HTML   PDF(2327KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  Objective: To construct a recombinant adenoviral vector modified by RGD-4C co-expressing inhibitor of growth 4 ( ING4 ) and phosphatase and tensin homolog deleted on chromosome ten (PTEN) and to study its inhibitory effects on human leukemia cell line MEG01. Methods:The recombinant adenovirus Ad.RGD-ING4-PTEN was obtained by gene recombination and in vitro packaging technique. Firstly, between the restriction enzyme cutting sites NotⅠand XhoⅠ, the PTEN fragment were inserted respectively, at the foundation of pAdTrack-CMV-ING4-polyA-promoter and pAdTrack-CMV-PolyA-promoter. Secondly, the transfered vector linearized by Pme I digestion and the backbone vector modified by RGD-4C were further co-transformed into the bacteria BJ5183 for homologous recombination. Lastly, the QBI-293A cell was used for packaging and amplification. The human leukemia cell line MEG01 was infected with Ad.RGD-ING4-PTEN. The infection efficiency of adenovirus to MEG01 was detected by flow cytometry. The expression of ING4 and PTEN was detected by Western blot. Cell growth inhibition was detected by CCK-8 assay. The cell apoptosis and the cell cycle were detected by flow cytometry. Results: The results of identification test show that the successful build of Ad.RGD-ING4-PTEN,the adenovirus which can express the double gene of ING4 and PTEN.It can infect MEG01 cell line effectively. The expression of ING4 and PTEN in MEG01 is obvious; ING4 and PTEN gene can significantly inhibit the growth of MEG01, induce its apoptosis and produce cycle arrest, and the fuction of double gene combination is more obvious than Single gene. Conclusion:Adenoviral vector modified by RGD-4C co-expressing ING4 and PTEN were successfully constructed. RGD-4C can significantly improve the efficiency of the infection to human leukemia cell line MEG01. Ad.RGD-ING4-PTEN can inhibit the cell growth of MEG01 and induce its apoptosis and block the cell cycle.

Key wordsAdenovirus      ING4      PTEN      Leukemia     
Received: 24 December 2013      Published: 25 March 2014
ZTFLH:  Q813  
Cite this article:

HUANG Chen, WANG Jia-rong, YANG Ji-cheng, SHENG Wei-hua, MIAO Jing-cheng. The Inhibition of Ad. RGD-ING4-PTEN on MEG01 Human Leukemia Cell. China Biotechnology, 2014, 34(3): 9-17.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20140302     OR     https://manu60.magtech.com.cn/biotech/Y2014/V34/I3/9

[1] Oren M, Damalas A, Gottlieb T, et al. Regulation of p53: intricate loops and delicate balances. Biochem Pharmacol, 2002, 64(5-6):865-871.
[2] Shiseki M, Nagashima M, Pedeux RM, et al. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res, 2003, 63(10):2373-2378.
[3] Zhang X, Wang K S, Wang Z Q, et al. Nuclear localization signal of ING4 plays a key role in its binding to p53. Biochem Biophys Res Commun, 2005, 331(4):1032-1038.
[4] Zhang X, Xu L S, Wang Z Q, et al. ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells. FEBS Lett, 2004, 570(1-3):7-12.
[5] Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell, 2008, 133(3):403-414.
[6] Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol, 1996, 12(697-715.
[7] Dmitriev I, Krasnykh V, Miller CR, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol, 1998, 72(12):9706-9713.
[8] Schmidt MR, Piekos B, Cabatingan MS, et al. Expression of a human coxsackie/adenovirus receptor transgene permits adenovirus infection of primary lymphocytes. J Immunol, 2000, 165(7):4112-4119.
[9] 张海峰, 章春花, 盛伟华, 等. 腺病毒介导的PTEN对A549肺癌细胞体内外生长的影响. 中国肿瘤生物治疗杂志, 2007, 14(2):173-178. Zhang H F, Zhang CH H, Sheng W H, et al. Influence of adenovirus mediated PTEN gene on growth of A549 cells in vitro and in vivo. Chinese Journal of Cancer Biotherapy, 2007, 14(2):173-178.
[10] Xie Y, Zhang H, Sheng W, et al. Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis. Cancer Lett, 2008, 271(1):105-116.
[11] Xie Y, Lv H, Sheng W, et al. Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells. Cancer Biother Radiopharm, 2011, 26(6):681-695.
[12] Garkavtsev I, Kozin S V, Chernova O, et al. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature, 2004, 428(6980):328-332.
[13] Song M S, Salmena L, Pandolfi P P. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol, 2012, 13(5):283-296.
[14] Sengupta S, Ulasov I V, Thaci B, et al. Enhanced transduction and replication of RGD-fiber modified adenovirus in primary T cells. PLoS One, 2011, 6(3):e18091.
[1] HUANG Lei,WAN Chang-qing,LIU Mei-qin,ZHAO Min,ZHENG Yan-peng,PENG Xiang-lei,YU Jie-mei,FU Yuan-hui,HE Jin-sheng. Construction of Recombinant Adenovirus Vectors Using the DNA Assembly Method[J]. China Biotechnology, 2021, 41(6): 23-26.
[2] CHEN Yu-qiong,TAN Wen-hua,LIU Hai-feng,CHEN Gen. Protective Effect of miR-29a on Lipopolysaccharide-induced Human Pulmonary Microvascular Endothelial Cells Injury by Targeting PTEN Expression[J]. China Biotechnology, 2021, 41(5): 8-16.
[3] TAO Shou-song,REN Guang-ming,YIN Rong-hua,YANG Xiao-ming,MA Wen-bing,GE Zhi-qiang. Knockdown of Deubiquitinase USP13 Inhibits the Proliferation of K562 Cells[J]. China Biotechnology, 2021, 41(5): 1-7.
[4] WANG Qian,CHEN Su-ning. The Genetics of Mixed-phenotype Acute Leukemia[J]. China Biotechnology, 2019, 39(9): 91-97.
[5] HE Ling-ling,LUO Ting-ting,CHANG Yan,WANG Ya-zhe,YUAN Xiao-ying,SHI Wei-hua,LAI Yue-yun,SHI Hong-xia,QIN Ya-zhen,HUANG Xiao-jun,LIU Yan-rong. Analysis on the Laboratory Examination Characteristics in 28 Patients with Acute Megakaryoblastic Leukemia[J]. China Biotechnology, 2019, 39(9): 2-10.
[6] ZHAO Si-shu,LIU Lu,LIU Fang,QIU Hai-rong,FAN Lei,LI Jian-yong,WU Yu-jie. Diagnostic Value of CD11c Antigen in Patients with Chronic Lymphocytic Leukemia[J]. China Biotechnology, 2019, 39(9): 19-24.
[7] ZHANG Jian,JIANG Zhi-ping,XU Ping,HE Qun,WANG Qing,ZHU Yan,ZHAO Xie-lan. Study on Monitoring of Imatinib Serum Level Guides Management of Chronic Myelogenous Leukemia Patients[J]. China Biotechnology, 2019, 39(9): 25-32.
[8] QIN Ya-zhen. Detection and the Clinical Significance of Molecular Markers in the Diagnosis and Treatment of Leukemia[J]. China Biotechnology, 2019, 39(9): 98-102.
[9] Lu WANG,Li-yuan YANG,Yu-ting TANG,Yao TAO,Li LEI,Yi-pei JING,Xue-ke JIANG,Ling ZHANG. Effects of PKM2 Knockdown on Proliferation and Apoptosis of Human Leukemia Cells and Its Potential Mechanism[J]. China Biotechnology, 2019, 39(3): 13-20.
[10] LI Rong-qing,QUAN Chun-shan,ZHANG Li-ying,LIU Jia-lu,ZHANG Xiang,SHANG Fei. Progress in the Synthesis of Artificial Antigen[J]. China Biotechnology, 2018, 38(12): 65-75.
[11] ZHANG He-ming, CAI Chu-fan, LIU Yang, GAN Long-zhan, JIAO Xue-miao, TIAN Yong-qiang. Soluble Expression of Human Leukemia Inhibitory Factor in Prokaryotic Cells and Its Purification[J]. China Biotechnology, 2017, 37(9): 7-14.
[12] ZENG Jie. Development and Application of L-Asparaginase with Better Performance and Advances in Recombinant Expression[J]. China Biotechnology, 2017, 37(11): 123-131.
[13] LI Hong-chang, YUAN Lin, ZHANG Ling-qiang . Construction of Transgenic Mice and Phenotypic Analysis of Tumor Suppressor PTEN[J]. China Biotechnology, 2015, 35(8): 1-8.
[14] ZHOU Yan, WANG Xiao-nan, YAN Shan-shan, WU Jin-yuan, SUN Mao-sheng, ZHANG Lei, LI Hong-jun. Construction and Coexpression of Recombinant Adenovirus Containing EGFP and Lmx1A[J]. China Biotechnology, 2014, 34(9): 72-79.
[15] ZHOU Nian, HU Ning, GONG Xuan, WANG Chang-dong, LIAO Jun-yi, LIANG Xi, HUANG Wei. Construction and Identification of Recombinant Adenovirus Ad-HIF1α[J]. China Biotechnology, 2014, 34(3): 34-40.